**Core Concept**
MgSO4 (Magnesium sulfate) is a commonly used medication in the management of eclampsia, a severe complication of preeclampsia characterized by seizures in pregnant women. The primary mechanism of MgSO4 in eclampsia is to stabilize neuronal membranes and prevent seizures by blocking voltage-gated calcium channels.

**Why the Correct Answer is Right**
During treatment with MgSO4, a patient develops a respiratory rate of 24 breaths per minute, a cardiac output of 6 liters per minute, and a urine output of 100 mL per hour. In this scenario, MgSO4 is not contraindicated because the patient does not exhibit any signs of magnesium toxicity, which includes respiratory depression, cardiac arrest, or decreased urine output.

**Why Each Wrong Option is Incorrect**
**Option A:** Respiratory rate of 20 breaths per minute is within the normal range for a pregnant woman, and it is not an indication to stop MgSO4 treatment.
**Option B:** Cardiac output of 6 liters per minute is lower than the normal range for a pregnant woman, but it is not an absolute contraindication for MgSO4 treatment.
**Option C:** Urine output of 50 mL per hour is decreased, which can be an early sign of magnesium toxicity, making MgSO4 contraindicated in this scenario.

**Clinical Pearl / High-Yield Fact**
MgSO4 can cause respiratory depression, cardiac arrest, and decreased urine output in cases of magnesium toxicity, which is a life-threatening complication. It is essential to closely monitor patients receiving MgSO4 for any signs of toxicity.

**Correct Answer: D.**